1-7 of 7
Henry Brem
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B06: Repositioning the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma

Sakibul Huq, Joshua Casaos, Michael Peters, Yuanxuan Xia, Andy Ding, Manuel Morales, Noah Gorelick, Riccardo Serra, Tianna Zhao, Wataru Ishida, Alexander Perdomo-Pantoja, Arba Cecia, Chenchen Ji, Ian Suk, David Sidransky, Mariana Brait, Henry Brem, Nicolas Skuli, Betty Tyler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): B06.
https://doi.org/10.1158/1557-3265.AACRAHNS19-B06
Published: 15 June 2020
View articletitled, Abstract B06: Repositioning the FDA-approved antiviral drug ribavirin as targeted therapy for nasopharyngeal carcinoma
Journal Articles

Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste

Stuart J. Smith, Betty M. Tyler, Toby Gould, Gareth J. Veal, Noah Gorelick, Jonathan Rowlinson, Riccardo Serra, Alison Ritchie, Phillip Berry, Annette Otto, John Choi, Nicolas Skuli, Maria Estevez-Cebrero, Kevin M. Shakesheff, Henry Brem, Richard G. Grundy, Ruman Rahman
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (16): 5094–5106.
https://doi.org/10.1158/1078-0432.CCR-18-3850
Published: 15 August 2019
View articletitled, Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste
Open the PDF for Overall Survival in Malignant Glioma Is Significantly Prolonged by Neurosurgical Delivery of Etoposide and Temozolomide from a Thermo-Responsive Biodegradable Paste in another window
Includes: Supplementary data
Journal Articles

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

Jennifer E. Kim, Mira A. Patel, Antonella Mangraviti, Eileen S. Kim, Debebe Theodros, Esteban Velarde, Ann Liu, Eric W. Sankey, Ada Tam, Haiying Xu, Dimitrios Mathios, Christopher M. Jackson, Sarah Harris-Bookman, Tomas Garzon-Muvdi, Mary Sheu, Allison M. Martin, Betty M. Tyler, Phuoc T. Tran, Xiaobu Ye, Alessandro Olivi, Janis M. Taube, Peter C. Burger, Charles G. Drake, Henry Brem, Drew M. Pardoll, Michael Lim
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1): 124–136.
https://doi.org/10.1158/1078-0432.CCR-15-1535
Published: 02 January 2017
View articletitled, Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
Open the PDF for Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas in another window
Includes: Supplementary data
Journal Articles

Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination

Christopher M. Jackson, Christina M. Kochel, Christopher J. Nirschl, Nicholas M. Durham, Jacob Ruzevick, Angela Alme, Brian J. Francica, Jimmy Elias, Andrew Daniels, Thomas W. Dubensky, Jr, Peter Lauer, Dirk G. Brockstedt, Emily G. Baxi, Peter A. Calabresi, Janis M. Taube, Carlos A. Pardo, Henry Brem, Drew M. Pardoll, Michael Lim, Charles G. Drake
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (5): 1161–1172.
https://doi.org/10.1158/1078-0432.CCR-15-1516
Published: 29 February 2016
View articletitled, Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination
Open the PDF for Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination in another window
Includes: Supplementary data
Journal Articles

Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells

Seogkyoung Kong, Sadhak Sengupta, Betty Tyler, Anthony J. Bais, Qiangzhong Ma, Saryn Doucette, Jinyuan Zhou, Ayguen Sahin, Bob S. Carter, Henry Brem, Richard P. Junghans, Prakash Sampath
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5949–5960.
https://doi.org/10.1158/1078-0432.CCR-12-0319
Published: 06 November 2012
View articletitled, Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells
Open the PDF for Suppression of Human Glioma Xenografts with Second-Generation IL13R-Specific Chimeric Antigen Receptor–Modified T Cells in another window
Includes: Supplementary data
Journal Articles

In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas

John P. Fruehauf, Henry Brem, Steven Brem, Andrew Sloan, Geoffrey Barger, Weidong Huang, Ricardo Parker
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4523–4532.
https://doi.org/10.1158/1078-0432.CCR-05-1830
Published: 09 August 2006
View articletitled, In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas
Open the PDF for In vitro Drug Response and Molecular Markers Associated with Drug Resistance in Malignant Gliomas in another window
Journal Articles

Polilactofate Microspheres for Paclitaxel Delivery to Central Nervous System Malignancies

Khan W. Li, Wenbin Dang, Betty M. Tyler, Greg Troiano, Tarik Tihan, Henry Brem, Kevin A. Walter
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3441–3447.
Published: 05 September 2003
View articletitled, Polilactofate Microspheres for Paclitaxel Delivery to Central Nervous System Malignancies
Open the PDF for Polilactofate Microspheres for Paclitaxel Delivery to Central Nervous System Malignancies in another window